A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

Conditions

• Sickle Cell Disease

Interventions

• DRUG: Aes-103
• DRUG: Aes-103
• DRUG: Aes-103
• DRUG: Aes-103
• DRUG: Placebo

Sponsor

Baxalta now part of Shire

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]